Literature DB >> 3533122

States of anxiety and their induction by drugs.

M Lader, M Bruce.   

Abstract

Syndromes of anxiety include generalized anxiety states, various forms of phobic disorder and panic attacks. It is unclear whether panic attacks are a separate syndrome from anxiety states or a more severe form. Drug-induced states of anxiety should provide useful models of the mechanisms of anxiety and its treatment. High-risk populations might be identifiable. Catecholamine infusions produce marked peripheral changes without fully reproducing the central feelings. Lactate infusions also produce anxiety-like states lacking full credibility. Experience with the benzodiazepine-receptor contragonists, the beta-carbolines, is limited but panic states have been reproduced following their use. Caffeine produces an anxiety state in high dose and some panic states have been induced. The critical evaluation of drug-induced anxiety states is a promising way of elucidating the mechanisms, psychological and physiological, associated with clinical anxiety.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533122      PMCID: PMC1401129          DOI: 10.1111/j.1365-2125.1986.tb02884.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  63 in total

1.  Metrazol tolerance in a normal voluntser population; an investigation of the potential significance of abnormal findings.

Authors:  E RODIN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1958-08

2.  The role of body attitudes and acquiescence in epinephrine and placebo effects.

Authors:  G J Fast; S Fisher
Journal:  Psychosom Med       Date:  1971 Jan-Feb       Impact factor: 4.312

3.  Anxiety precipitated by lactate.

Authors:  M Fink; M A Taylor; J Volavka
Journal:  N Engl J Med       Date:  1969-12-18       Impact factor: 91.245

4.  Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood.

Authors:  A Goldstein; S Kaizer; R Warren
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

5.  Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse.

Authors:  J N Crawley; P Skolnick; S M Paul
Journal:  Neuropharmacology       Date:  1984-05       Impact factor: 5.250

6.  Lactate metabolism in anxiety neurosis.

Authors:  F N Pitts; J N McClure
Journal:  N Engl J Med       Date:  1967-12-21       Impact factor: 91.245

7.  The proconvulsant and diazepam-reversing effects of ethyl-beta-carboline-3-carboxylate.

Authors:  N R Oakley; B J Jones
Journal:  Eur J Pharmacol       Date:  1980-12-05       Impact factor: 4.432

8.  Benzodiazepine receptor-mediated experimental "anxiety" in primates.

Authors:  P T Ninan; T M Insel; R M Cohen; J M Cook; P Skolnick; S M Paul
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

Review 9.  Behavioral analogues of anxiety. Animal models.

Authors:  H Lal; M W Emmett-Oglesby
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

10.  A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.

Authors:  T R Insel; P T Ninan; J Aloi; D C Jimerson; P Skolnick; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1984-08
View more
  10 in total

1.  Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions.

Authors:  M H Thiébot; L Dangoumau; G Richard; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  FG 7142 and its anxiety-inducing effects in humans.

Authors:  R Dorow
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls.

Authors:  M H Thiébot; P Soubrié; D Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  Caffeine and health.

Authors:  C H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

5.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 6.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Effects of cocaine history on postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats.

Authors:  Chen Li; Lynn G Kirby
Journal:  Eur Neuropsychopharmacol       Date:  2015-11-21       Impact factor: 4.600

8.  Central effects of corticotropin releasing factor (CRF): evidence for similar interactions with environmental novelty and with caffeine.

Authors:  D R Britton; E Indyk
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Dose-dependent effects of intravenous lorazepam on cardiovascular activity, plasma catecholamines and psychological function during rest and mental stress.

Authors:  J H Tulen; P Moleman; F Boomsma; H G van Steenis; V J van den Heuij
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Caffeine Intake and Mental Health in College Students.

Authors:  Raphael A O Bertasi; Yasmine Humeda; Tais G O Bertasi; Zoe Zins; Justin Kimsey; George Pujalte
Journal:  Cureus       Date:  2021-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.